Hypovitaminosis C Prevalence and Risk Factors in an Acute Geriatric Unit
NCT05668663 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 434
Last updated 2025-09-03
Summary
Vitamin C is essential for numerous biological processes as it acts as a cofactor in various hydroxylation reactions, but also as a powerful antioxidant. As humans have lost the ability to synthetize Vitamin C, this micronutrient is found exclusively in the food, and more particularly in fresh fruits and vegetables.
The term 'hypovitaminosis C' refers to a plasmatic Vitamin C concentration \< 28 µmol/L. It encompasses two distinct situations, according to the severity of the deprivation:
* A deeply lowered plasmatic concentration (\< 11 µmol/L) is defined as 'Vitamin C deficiency'. The resulting condition is scurvy and its well-known haemorrhagic complications, very likely to be fatal.
* A less low plasmatic concentration (11-27 µmol/L) is defined as 'Vitamin C depletion'. Symptoms are polymorphic and less suggestive, especially for elderly patients. Many studies suggest a chronic Vitamin C depletion may favour the occurrence of various conditions such as cognitive impairment, psychiatric disorders, cardio-vascular diseases, or certain cancers, thereby highlighting the involvement of Vitamin C in many biological processes.
The epidemiology and risk factors of hypovitaminosis C in ageing populations are poorly documented. The few studies dealing with this question are mostly retrospective, including a low number of patients, and relying on an imperfect methodology. Despite these limitations, data suggest hypovitaminosis C could concern up to 50% of the hospitalized geriatric population.
Despite this probably high prevalence, hypovitaminosis C is barely diagnosed and thus rarely supplemented. This is particularly true for the elderlies who are at risk high of being Vitamin C depleted.
Moreover, several risk factors have been described to be associated with Vitamin C depletion or deficiency, sometimes both. But only a few of them have been validated for the geriatric population.
Thus, there is a real need for a better understanding of hypovitaminosis C epidemiology and risk factors in the geriatric population, in order to diagnose earlier, more frequently, and more precisely these cases. It is important to note that an easy and safe supplementation exists (1 g of Vitamin C for 2 weeks).
A better understanding of risk factors is also a key element to apply corrective measures on modifiable risk factors in order to prevent the recurrence of hypovitaminosis C.
In the present research protocol, the investigators hypothesized hypovitaminosis C could concern half of the hospitalized geriatric patients in acute care units.
The primary objective of this study is to evaluate the prevalence of hypovitaminosis C in a geriatric acute care unit, by using a prospective design and including a statistically sufficient number of patients.
The secondary objectives are :
* To determine in this population the prevalence of Vitamin C deficiency,
* To determine in this population the prevalence of Vitamin C depletion,
* To assess the statistical associations between hypovitaminosis C, deficiency, and depletion with already known or pertinent risk factors.
* To follow adverse events with vitamin C supplementation in deficient patients.
Conditions
- Deficiency, Vitamin C
Interventions
- DIAGNOSTIC_TEST
-
Plasmatic Vitamin C concentrations (known as ascorbemia) on a single blood sample
If the patient consents to participate in the study, a 4-mL blood sample will be collected and performed when the patient enters the unit. No other sample will be taken, and the participation of the patient to the study will end after the result of the test or after the end of the vitamin C supplementation. A telephone call is organized to follow up on any adverse effects. The blood sample will be collected up to 3 days after admission
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-01-09
- Primary Completion
- 2024-05-24
- Completion
- 2024-05-24
Countries
- France
Study Locations
More Related Trials
-
Vitamin Therapy in JGH Patients
NCT01630720 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study on the Variation of Ascorbic Acid in Patients Undergoing Solid Organ Transplantation
NCT06395259 ·Status: ACTIVE_NOT_RECRUITING
-
Systemic Adverse Effects After Osteopathic Treatment and Vitamin C
NCT06102577 ·Status: COMPLETED ·Phase: NA
-
Vitamin D Deficiency in Subjects With Chronic Hepatitis C Compared to Healthy Volunteers
NCT01274013 ·Status: WITHDRAWN
-
Vitamin C Administration and Triglycerides Level in Critical Care Patients
NCT06206759 ·Status: RECRUITING
-
Monocentric Randomized Study, Assessing the Interests of the Determination of Vitamin D in Prison Population. (Vitamine D)
NCT02044133 ·Status: COMPLETED ·Phase: NA
-
No Association Between Vitamin C and E Supplementation, Frailty, and Grip Strength Over Five Years: The CoLaus Study
NCT03258970 ·Status: COMPLETED
-
Covid-19 and Vitamin D in Nursing-home
NCT04435119 ·Status: COMPLETED
-
Predictive Questionnaire for Vitamin D Insufficiency in Healthy Adults
NCT02408679 ·Status: COMPLETED
-
Vitamin Deficiency and Blood Pressure in Hospitalized Jewish General Hospital (JGH) Patients
NCT00921622 ·Status: COMPLETED ·Phase: PHASE2
-
Vitamin D Insufficiency inVestigation Among hospitaLizeD Inpatients
NCT05214040 ·Status: NOT_YET_RECRUITING
-
Emulated Study of Vitamin D Correction Vs Non-Correction
NCT06366776 ·Status: ACTIVE_NOT_RECRUITING
-
The Impact of Qualia Vitamin C+ on Blood Vitamin C Levels
NCT07285109 ·Status: COMPLETED ·Phase: NA
-
Serum Vitamin D Levels in Critically Ill Patients Undergoing Regional Citrate Anticoagulation CRRT
NCT02414386 ·Status: COMPLETED
-
Vitamin D and Physical Function in Older Adults
NCT00710957 ·Status: COMPLETED
-
Study to Document the Phenomenon of Vitamin D Deficiency and Its Added Value in Patients with Low-energy Osteoporotic Hip Fracture, in Daily Practice in Greece.
NCT06643650 ·Status: RECRUITING
-
Replenishing and Maintaining Vitamin D Status in Older Adults in Residential Care Facilities in NI
NCT04395638 ·Status: SUSPENDED ·Phase: NA
-
Vitamin D Deficiency: Bone Loss and Vascular Dysfunction
NCT00235586 ·Status: COMPLETED ·Phase: NA
-
Vitamin K Status and Markers of Vascular Function in Patients With and Without Postural Hypotension
NCT02505282 ·Status: COMPLETED
-
Dietary Supplementation With 25-hydroxyvitamin D3 in Older Adults
NCT01398202 ·Status: COMPLETED ·Phase: NA
-
Vitamin D in Vulnerable Adults (VIVA-VA)
NCT01170273 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Vitamin D Supplementation in Older Persons
NCT00681590 ·Status: COMPLETED ·Phase: PHASE3
-
Vitamine d Dosage and Constipation
NCT03096704 ·Status: UNKNOWN
-
Hypovitaminosis D in Neurocritical Patients
NCT02881957 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Vitamin C as an Anti-cancer Drug
NCT01080352 ·Status: COMPLETED ·Phase: PHASE2